PPARA and metabolic dysfunction-associated steatotic liver disease: However, in Italian subjects the Leu162Val PPARα loss-of-function polymorphism did not influence the risk of NAFLD, where it was associated with IR but not histologically assessed disease severity [83], suggesting that the risk related to increased insulin resistance may be balanced by the protective effect of decreased oxidative stress.